Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Els Torreele

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Clinical Pharmacokinetics|February 19, 2014
Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studiesAntoine Tarral, Séverine Blesson, Olaf Valverde Mordt, et al.
Lancet (London, England)|January 15, 2023
Stopping epidemics when and where they occurEls Torreele, Michel Kazatchkine, Joanne Liu, et al.
Bulletin of the World Health Organization|May 9, 2017
Tuberculosis and antimicrobial resistance - new models of research and development neededGrania Brigden, José Luis Castro, Lucica Ditiu, et al.
Tropical Medicine & International Health : TM & IH|September 2, 2005
Control of mucocutaneous leishmaniasis, a neglected disease: results of a control programme in Satipo Province, PeruJean-Paul Guthmann, Doris Arlt, Luis Miguel Leon Garcia, et al.
The Lancet. Global Health|August 31, 2023
From private incentives to public health need: rethinking research and development for pandemic preparednessEls Torreele, Daniel Wolfe, Michel Kazatchkine, et al.
BMJ Global Health|January 9, 2024
Shaping the future of global access to safe, effective, appropriate and quality health productsRaffaella Ravinetto, Rodrigo Henriquez, Prashant N Srinivas, et al.
Plos Neglected Tropical Diseases|November 8, 2012
Fexinidazole: a potential new drug candidate for Chagas diseaseMaria Terezinha Bahia, Isabel Mayer de Andrade, Tassiane Assíria Fontes Martins, et al.
Lancet (London, England)|June 30, 2009
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trialGerardo Priotto, Serena Kasparian, Wilfried Mutombo, et al.
Lancet (London, England)|November 13, 2014
Randomised controlled trials for Ebola: practical and ethical issuesClement Adebamowo, Oumou Bah-Sow, Fred Binka, et al.
Nature|February 10, 2022
Reboot biomedical R&D in the global public interestSoumya Swaminathan, Bernard Pécoul, Hisham Abdullah, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Clinical Pharmacokinetics|February 19, 2014
Determination of an optimal dosing regimen for fexinidazole, a novel oral drug for the treatment of human African trypanosomiasis: first-in-human studiesAntoine Tarral, Séverine Blesson, Olaf Valverde Mordt, et al.
Lancet (London, England)|January 15, 2023
Stopping epidemics when and where they occurEls Torreele, Michel Kazatchkine, Joanne Liu, et al.
Bulletin of the World Health Organization|May 9, 2017
Tuberculosis and antimicrobial resistance - new models of research and development neededGrania Brigden, José Luis Castro, Lucica Ditiu, et al.
Tropical Medicine & International Health : TM & IH|September 2, 2005
Control of mucocutaneous leishmaniasis, a neglected disease: results of a control programme in Satipo Province, PeruJean-Paul Guthmann, Doris Arlt, Luis Miguel Leon Garcia, et al.
The Lancet. Global Health|August 31, 2023
From private incentives to public health need: rethinking research and development for pandemic preparednessEls Torreele, Daniel Wolfe, Michel Kazatchkine, et al.
BMJ Global Health|January 9, 2024
Shaping the future of global access to safe, effective, appropriate and quality health productsRaffaella Ravinetto, Rodrigo Henriquez, Prashant N Srinivas, et al.
Plos Neglected Tropical Diseases|November 8, 2012
Fexinidazole: a potential new drug candidate for Chagas diseaseMaria Terezinha Bahia, Isabel Mayer de Andrade, Tassiane Assíria Fontes Martins, et al.
Lancet (London, England)|June 30, 2009
Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trialGerardo Priotto, Serena Kasparian, Wilfried Mutombo, et al.
Lancet (London, England)|November 13, 2014
Randomised controlled trials for Ebola: practical and ethical issuesClement Adebamowo, Oumou Bah-Sow, Fred Binka, et al.
Nature|February 10, 2022
Reboot biomedical R&D in the global public interestSoumya Swaminathan, Bernard Pécoul, Hisham Abdullah, et al.
Pageof 6